EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting

Yoshihiro Aizawa, Kentaro Takada, Jun Aoyama, Daisuke Sano, Shoji Yamanaka, Masahide Seki, Yuta Kuze, Jordan A Ramilowski, Ryo Okuda, Yasuharu Ueno, Yusuke Nojima, Yoshiaki Inayama und 8 weitere

Cellular Oncology · 2023-04 · 46 (2) · 409-421

DOI: 10.1007/s13402-022-00758-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 20.12.2022. Verfasst von Yoshihiro Aizawa und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004,…. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Yokohama City University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Depending on its histological subtype, salivary gland carcinoma (SGC) may have a poor prognosis. Due to the scarcity of preclinical experimental models, its molecular biology has so far remained largely unknown, hampering the development of new treatment modalities for patients with these malignancies. The aim of this study was to generate experimental human SGC models of multiple histological subtypes using patient-derived xenograft (PDX) and organoid culture techniques.

Methods

Tumor specimens from surgically resected SGCs were processed for the preparation of PDXs and patient-derived organoids (PDOs). Specimens from SGC PDXs were also processed for PDX-derived organoid (PDXO) generation. In vivo tumorigenicity was assessed using orthotopic transplantation of SGC organoids. The pathological characteristics of each model were compared to those of the original tumors using immunohistochemistry. RNA-seq was used to analyze the genetic traits of our models.

Results

Three series of PDOs, PDXs and PDXOs of salivary duct carcinomas, one series of PDOs, PDXs and PDXOs of mucoepidermoid carcinomas and PDXs of myoepithelial carcinomas were successfully generated. We found that PDXs and orthotopic transplants from PDOs/PDXOs showed similar histological features as the original tumors. Our models also retained their genetic traits, i.e., transcription profiles, genomic variants and fusion genes of the corresponding histological subtypes.

Conclusion

We report the generation of SGC PDOs, PDXs and PDXOs of multiple histological subtypes, recapitulating the histological and genetical characteristics of the original tumors. These experimental SGC models may serve as a useful resource for the development of novel therapeutic strategies and for investigating the molecular mechanisms underlying the development of these malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsAnimalsHumansTransplantation, HeterologousDisease Models, AnimalPhenotypeOrganoidsXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Organoid culturePDX-derived organoid (PDXO)Patient derived xenograft (PDX)Patient-derived organoid (PDO)Salivary gland cancer

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Department of Otorhinolaryngology, Head and Neck Surgery, School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan. dsano@yokohama-cu.ac.jp.
  • Department of Pathology, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
  • Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba, Japan.
  • Advanced Medical Research Center, Yokohama City University, Kanagawa, Japan.
  • Roche Innovation Center, Roche Institute for Translational Bioengineering, Roche Pharma Research and Early Development, Basel, Switzerland.

Förderung

  • Japan Society for the Promotion of Science
  • Ministry of Education, Culture, Sports, Science and Technology
  • Yokohama City University

Zitieren

APA

Aizawa, Y., Takada, K., Aoyama, J., Sano, D., Yamanaka, S., Seki, M., Kuze, Y., Ramilowski, J. A., Okuda, R., Ueno, Y., Nojima, Y., Inayama, Y., Hatakeyama, H., Hatano, T., Takahashi, H., Nishimura, G., Fujii, S., Suzuki, Y., Taniguchi, H., & Oridate, N. (2023). Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting. Cellular Oncology, 46(2), 409-421. https://doi.org/10.1007/s13402-022-00758-6

Vancouver

Aizawa Y, Takada K, Aoyama J, Sano D, Yamanaka S, Seki M, et al. Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting. Cellular Oncology. 2023;46(2):409-421. doi:10.1007/s13402-022-00758-6

BibTeX
@article{Aizawa2023,
  author = {Aizawa, Yoshihiro and Takada, Kentaro and Aoyama, Jun and Sano, Daisuke and Yamanaka, Shoji and Seki, Masahide and Kuze, Yuta and Ramilowski, Jordan A and Okuda, Ryo and Ueno, Yasuharu and Nojima, Yusuke and Inayama, Yoshiaki and Hatakeyama, Hiromitsu and Hatano, Takashi and Takahashi, Hideaki and Nishimura, Goshi and Fujii, Satoshi and Suzuki, Yutaka and Taniguchi, Hideki and Oridate, Nobuhiko},
  title = {Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting},
  journal = {Cellular Oncology},
  year = {2023},
  volume = {46},
  number = {2},
  pages = {409--421},
  doi = {10.1007/s13402-022-00758-6}
}
Kostenlos starten →